The University of Toronto has partnered with Astellas Pharma to create the Astellas Prostate Cancer Innovation Fund with the purpose of supporting and advancing prostate cancer research.
Under the direction and supervision of an interdisciplinary UofT review committee, overseen by the Chair of the Division of Urology, the Fund will provide 3 grants in the amount of $50,000. Grants are open to faculty members in the Faculty of Medicine and across UofT’s affiliated hospitals and research institutes, with academic appointment to the following Departments: Surgery; Medicine; Laboratory Medicine & Pathobiology; Radiation Oncology; or Medical Imaging. Please see attached for the formal Call for Applications and Terms of Reference.